Cargando…

Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells

Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Chen-Hsi, Chao, K. S. Clifford, Liao, Hui-Fen, Chen, Yu-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773992/
https://www.ncbi.nlm.nih.gov/pubmed/24073010
http://dx.doi.org/10.1155/2013/838651
_version_ 1782284452884381696
author Hsieh, Chen-Hsi
Chao, K. S. Clifford
Liao, Hui-Fen
Chen, Yu-Jen
author_facet Hsieh, Chen-Hsi
Chao, K. S. Clifford
Liao, Hui-Fen
Chen, Yu-Jen
author_sort Hsieh, Chen-Hsi
collection PubMed
description Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead to angiogenesis, migration, invasion, and metastasis. Multidrug resistance (MDR) is an unfavorable factor causing the failure of treatments against cancer cells. The most important and thoroughly studied mechanism involved in MDR is the active efflux of chemotherapeutic agents through membrane drug transporters. There is growing evidence that Norcantharidin (NCTD), a water-soluble synthetic small molecule derivative of naturally occurring cantharidin from the medicinal insect blister beetle (Mylabris phalerata Pallas), is capable of chemoprevention and tumor inhibition. We summarize investigations into the modulation of self-renewal pathways and MDR in CSCs by NCTD. This review may aid in further investigation of using NCTD to develop more effective strategies for cancer treatment to reduce resistance and recurrence.
format Online
Article
Text
id pubmed-3773992
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37739922013-09-26 Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells Hsieh, Chen-Hsi Chao, K. S. Clifford Liao, Hui-Fen Chen, Yu-Jen Evid Based Complement Alternat Med Review Article Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead to angiogenesis, migration, invasion, and metastasis. Multidrug resistance (MDR) is an unfavorable factor causing the failure of treatments against cancer cells. The most important and thoroughly studied mechanism involved in MDR is the active efflux of chemotherapeutic agents through membrane drug transporters. There is growing evidence that Norcantharidin (NCTD), a water-soluble synthetic small molecule derivative of naturally occurring cantharidin from the medicinal insect blister beetle (Mylabris phalerata Pallas), is capable of chemoprevention and tumor inhibition. We summarize investigations into the modulation of self-renewal pathways and MDR in CSCs by NCTD. This review may aid in further investigation of using NCTD to develop more effective strategies for cancer treatment to reduce resistance and recurrence. Hindawi Publishing Corporation 2013 2013-09-02 /pmc/articles/PMC3773992/ /pubmed/24073010 http://dx.doi.org/10.1155/2013/838651 Text en Copyright © 2013 Chen-Hsi Hsieh et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hsieh, Chen-Hsi
Chao, K. S. Clifford
Liao, Hui-Fen
Chen, Yu-Jen
Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
title Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
title_full Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
title_fullStr Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
title_full_unstemmed Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
title_short Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
title_sort norcantharidin, derivative of cantharidin, for cancer stem cells
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773992/
https://www.ncbi.nlm.nih.gov/pubmed/24073010
http://dx.doi.org/10.1155/2013/838651
work_keys_str_mv AT hsiehchenhsi norcantharidinderivativeofcantharidinforcancerstemcells
AT chaoksclifford norcantharidinderivativeofcantharidinforcancerstemcells
AT liaohuifen norcantharidinderivativeofcantharidinforcancerstemcells
AT chenyujen norcantharidinderivativeofcantharidinforcancerstemcells